Between cost and demand, Wegovy and other weight-loss medications could transform healthcare in the U.S.—for good and ill.Novo Nordisk are about to start raking in tens of billions of dollars a year on their new obesity drugs, say Wall Street analysts. That’s great news for the drugmakers, certainly, but it could be a disaster for […]
